Published on Microbicide Trials Network (http://www.mtnstopshiv.org)

Home > HPTN 035

HPTN 035

A multi-center clinical trial evaluating the safety and effectiveness of two different candidate microbicides, BufferGel® and PRO 2000, in 3,100 sexually active HIV-negative women at seven sites in Africa and the United States. Results have been reported.  (See news release below.)
 
See
Dec 14, 2009
  
Dec 14, 2009
  
Feb 9, 2009
 
 
 
 
See Also
 
Feb 9, 2009
 
Watch
Feb 9, 2009
Printer-friendly version [10]
Source URL: http://www.mtnstopshiv.org/news/studies/hptn035

Links:
[1] http://www.mtnstopshiv.org/node/1595
[2] http://www.mtnstopshiv.org/node/1594
[3] http://www.mtnstopshiv.org/node/765
[4] http://www.mtnstopshiv.org/news/studies/hptn035/backgrounder
[5] http://www.mtnstopshiv.org/news/studies/hptn035/facts
[6] http://www.mtnstopshiv.org/news/studies/hptn035/qa
[7] http://www.mtnstopshiv.org/sites/default/files/attachments/HPTN035v3.pdf
[8] http://www3.niaid.nih.gov/news/newsreleases/2009/HPTN_035_gel.htm
[9] http://tinyurl.com/dc7dng
[10] http://www.mtnstopshiv.org/print/768

Media Contacts:

Lisa Rossi -- Office: +1 412 641-8940 -- Mobile: +1 412 916-3315 -- Email: rossil@upmc.edu

Clare Collins -- Office: +1 412 641-7299 -- Mobile: +1 412 770-8643 -- Email: collcx@upmc.edu